USPTO serial 79362445
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
IT
IT
IT
IT
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances for analyses in laboratories, other than for medical or veterinary purposes, chemical for use in industry and natural elements, namely, radiative elements for scientific purposes; nucleic acid sequencing programs other than for medical use, namely, nucleic acid sequences and chemical reagents for other than medical or veterinary purposes; chemical compositions and materials for use in science, namely, chemicals for use in science; chemical reagent mixtures in kit form comprised of chemical reagents other than for medical or veterinary use; chemical reagents other than for medical or veterinary purposes for use in the field of scientific research; chemicals for use in performing nucleic acid polymerase chain reactions other than medical and veterinary purposes; chemical diagnostic reagents for industrial purposes, namely, cellular culture environments, cellular regulation agents, amino acids, dna fragments, rna fragments, dna probes, rna probes, material for genetic cloning, tagged antibodies for laboratory use; protein in raw material form for scientific and medical research; photosensitive chemicals being chemical preparations for use in photography; activators being chemicals for use in industry and science | ACTIVE | — |
| 005 | Stem cells for medical purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for medical purposes, namely, for treating cancer; chemical preparations for pharmaceutical purposes for the treatment of renal disease; diagnostic preparations for medical purposes, namely, for diagnosing cardiovascular conditions; pharmaceutical preparations for treating cancer; clinical diagnostic reagents being diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; swabs for medical purposes; biological reagents for medical use; biotechnological preparations for medical use for treating cancer; antibodies, namely, colostral antibodies for medical purposes; regulatory proteins for medical use, namely, protein arrays for medical diagnosis purposes; enzymes for medical and veterinary purposes | ACTIVE | — |
| 010 | Screening kit, namely, apparatus for DNA and RNA testing for medical purposes; biomedical diagnostic apparatus, namely, molecular diagnostic devices for medical purposes used for nucleic acid testing, infectious disease testing, genetic testing; biomedical devices in the nature of cartridges, unfilled, for medical purposes, for loading biological samples for use in molecular diagnostic devices; testing sample collection equipment, namely, swabs for obtaining biological samples from subjects for biomedical purposes; apparatus for dna and rna testing for medical purposes; apparatus for carrying-out diagnostic tests for medical purposes, namely, apparatus for DNA and RNA testing for medical purposes; screening kits for medical purposes, namely, apparatus for DNA and RNA testing for medical purposes; probes for medical purposes; sensor apparatus for medical use in diagnosis, namely, patient monitoring sensors and alarms | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 18, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 17, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 9, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 7, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 6, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 23, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 3, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 3, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 14, 2024 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 14, 2024 | ALIE | ASSIGNED TO LIE | — |
| Mar 5, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 5, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 27, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 9, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 9, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 9, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 9, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 9, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 2, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 2, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 29, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 9, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 9, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 4, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 3, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 27, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 27, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 15, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 11, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 9, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |